Skip to content

Double-S: a Wearable Device for Erectile Dysfunction

Double-S: a Wearable Device for Erectile Dysfunction

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05451563
Enrollment
10
Registered
2022-07-11
Start date
2024-03-21
Completion date
2026-06-30
Last updated
2025-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction

Brief summary

The purpose of this study is to use a minimally invasive erectile device for patients suffering from erectile dysfunction.

Detailed description

The purpose of the study is to use a minimally invasive erectile device support to provide to patients suffering from erectile dysfunction the possibility to achieve satisfactory penetrating intercourse. The goal of this is to help men who have issues with erectile function (e.g.after radical prostatectomy for prostate cancer, vascular or metabolic erectile dysfunction non-responsive to phosphodiesterase-5 inhibitor medications, etc.) to have medication-free mechanical support for their penis in order to obtain sexual penetration satisfactorily.

Interventions

DEVICEDouble-S

Wearable device for intercourse

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* males \>18 years old suffering from any cause moderate to severe erectile dysfunction (e.g. ED after radical prostatectomy and/or radiation therapy for prostate cancer and or other pelvic malignancies affecting the sexual potency; emotional and psychological ED; organic vascular and/or metabolic ED etc.) * having a female partner willing to participate in the study

Exclusion criteria

* not willing to attempt sexual vaginal intercourse with their partner * inability to wear/operate the external penile device for any reason

Design outcomes

Primary

MeasureTime frameDescription
Change in modified International Index of Erectile Dysfunction scorebaseline and up to 1 month post-baselinescore 0 to 30 with higher score meaning better erectile function

Countries

United States

Contacts

Primary ContactSatvir Basran
sbasran@stanford.edu650-723-0948

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026